Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases

Despite advances in adjuvant therapy for breast cancer, bone remains the most common site of recurrence. The goal of therapy for these patients is palliative and focused on maximizing the duration and quality of their life, while concurrently minimizing any disease or treatment-related complications...

Descripción completa

Detalles Bibliográficos
Autores principales: Simos, Demetrios, Addison, Christina L., Kuchuk, Iryna, Hutton, Brian, Mazzarello, Sasha, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470229/
https://www.ncbi.nlm.nih.gov/pubmed/26237063
http://dx.doi.org/10.3390/jcm2030067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470229/
https://www.ncbi.nlm.nih.gov/pubmed/26237063
http://dx.doi.org/10.3390/jcm2030067

Ejemplares similares